BioMarin to Host Third Quarter 2022 Financial Results Conference Call and Webcast on Wednesday, October 26, at 4:30pm ET

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host a conference call and webcast on October 26, 2022, at 4:30 p.m. ET to discuss its third quarter 2022 financial results and provide a general business update. This follows the market's closure on the same day. Interested participants can access the event via BioMarin's investor section on their website. The company focuses on developing innovative therapies for serious genetic diseases, with eight commercial products and numerous candidates in development.

Positive

• Preparation for Q3 earnings call suggests transparency and investor engagement.
• Company's focus on innovative therapies may lead to growth opportunities.

Negative

• None.

SAN RAFAEL, Calif., Oct. 4, 2022 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Wednesday, October 26^th, at 4:30 p.m. ET to discuss third quarter 2022 financial results and provide a general business update.

Dial-in Number 
U.S. / Canada Dial-in Number: 800-831-4163
International Dial-in Number: 213-992-4616

U.S. / Canada Replay Dial-in Number: 800-645-7964
International Replay Dial-in Number: 757-849-6722
Playback ID: 2361#

BioMarin to Announce 3Q22 Financial Results October 26th, 2022 After the Market Closes

 Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.biomarin.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening genetic diseases and medical conditions. The Company selects product candidates for diseases and conditions that represent a significant unmet medical need, have well-understood biology and provide an opportunity to be first-to-market or offer a significant benefit over existing products. The Company's portfolio consists of eight commercial products and multiple clinical and preclinical product candidates for the treatment of various diseases. For additional information, please visit www.biomarin.com.  

Contacts:
Investors	Media
Traci McCarty	Debra Charlesworth
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 455-7451

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-third-quarter-2022-financial-results-conference-call-and-webcast-on-wednesday-october-26-at-430pm-et-301639963.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin announce its Q3 2022 financial results?

BioMarin will announce its Q3 2022 financial results on October 26, 2022.

What time is BioMarin's conference call for Q3 2022 earnings?

The conference call for BioMarin's Q3 2022 earnings will take place at 4:30 p.m. ET.

How can I access BioMarin's earnings call?

You can access BioMarin's earnings call via the investor section of their website.

What is the focus of BioMarin Pharmaceutical?

BioMarin focuses on developing therapies for serious and life-threatening genetic diseases.

What products does BioMarin currently have?

BioMarin has eight commercial products and multiple clinical and preclinical product candidates.